Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis

Responsible for 9 million new cases of active disease and nearly 2 million deaths each year, tuberculosis (TB) remains a global health threat of overwhelming dimensions. Mycobacterium bovis BCG, the only licensed vaccine available, fails to confer lifelong protection and to prevent reactivation of l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Vaccine Immunol
Päätekijät: Coppola, Mariateresa, van den Eeden, Susan J. F., Wilson, Louis, Franken, Kees L. M. C., Ottenhoff, Tom H. M., Geluk, Annemieke
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2015
Aiheet:
Vaccines
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550671/
https://ncbi.nlm.nih.gov/pubmed/26202436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00271-15
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia